The novel ASPL-TFE3 dual-fusion probe is designed here for the first time using in diagnosing Xp11.2 tRCC. The gene discussed is ASPSCR1; the disease is renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.